Skip to content

Tectonic Therapeutics TECX Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

ALN
Alnylam PharmaceuticalsALNY
Septerna, Inc. logo
Septerna, Inc.SEPN
Regenxbio logo
RegenxbioRGNX
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
Opko Health logo
Opko HealthOPK
Ginkgo Bioworks logo
Ginkgo BioworksDNA

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's software and technology licenses, net?
Tectonic Therapeutics (TECX) reported software and technology licenses, net of $663K in Q1 2026.
How has Tectonic Therapeutics's software and technology licenses, net changed year-over-year?
Tectonic Therapeutics's software and technology licenses, net increased by 380.4% year-over-year, from $138K to $663K.
What is the long-term trend for Tectonic Therapeutics's software and technology licenses, net?
Over 5 years (2020 to 2025), Tectonic Therapeutics's software and technology licenses, net has grown at a 8.0% compound annual growth rate (CAGR), from $436K to $640K.